SCHEMBL21998261

SCHEMBL21998261

CNCCN(C)C(=O)CCCCCNC(=O)CCCCC1SCC2NC(=O)NC21

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 5/20 0.62
▸ F2 P00734 1/20 0.57
▸ PRSS1 P07477 1/20 0.57
▸ PRSS2 P07478 1/20 0.57
▸ PRSS3 P35030 1/20 0.57
▸ TPSAB1 Q15661 1/20 0.57
▸ FLI1 Q01543 1/20 0.54
▸ EWSR1 Q01844 1/20 0.54
▸ PLCD1 P51178 1/20 0.53
▸ ITGB1 P05556 1/20 0.53
▸ ITGA4 P13612 1/20 0.53
▸ CA12 O43570 2/20 0.53
▸ CA1 P00915 2/20 0.53
▸ CA2 P00918 2/20 0.53
▸ CA9 Q16790 2/20 0.53
▸ MEN1 O00255 1/20 0.53
▸ ABL1 P00519 1/20 0.53
▸ LMNA P02545 1/20 0.53
▸ PKM P14618 1/20 0.53
▸ IDE P14735 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8126600 0.92 TDP1 (0.63) TDP1F2PRSS1PRSS2PRSS3
SCHEMBL23074456 0.90 TDP1 (0.71) TDP1F2PRSS1PRSS2PRSS3
SCHEMBL20634852 0.89 TDP1 (0.70) TDP1F2PRSS1PRSS2PRSS3
SCHEMBL15949804 0.89 TDP1 (0.72) TDP1F2PRSS1PRSS2PRSS3
SCHEMBL16602265 0.87 TDP1 (0.62) TDP1F2PRSS1PRSS2PRSS3
SCHEMBL13826280 0.87 TDP1 (0.69) TDP1F2PRSS1PRSS2PRSS3
SCHEMBL17208780 0.87 TDP1 (0.69) TDP1F2PRSS1PRSS2PRSS3
SCHEMBL18313828 0.87 TDP1 (0.69) TDP1F2PRSS1PRSS2PRSS3
SCHEMBL18779801 0.87 TDP1 (0.78) TDP1F2PRSS1PRSS2PRSS3
SCHEMBL20005095 0.86 TDP1 (0.71) TDP1F2PRSS1PRSS2PRSS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200147232-A1 BIOCONJUGATES WITH A CONTROLLED DEGREE OF CONJUGATION, THEIR PROCESS OF PREPARATION, AND THE REAGENTS FOR THEIR PREPARATION SYNDIVIA (FR) 2020-05-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200147232-A1 BIOCONJUGATES WITH A CONTROLLED DEGREE OF CONJUGATION, THEIR PROCESS OF PREPARATION, AND THE REAGENTS FOR THEIR PREPARATION FCGR1A, FCGR2A, FCGR3B TDP1 3919/4885F2 1282/4885PRSS1 2753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback